These data demonstrate that 131I-antiAFPMcAb-GCV-BSA-NPs have a strong selectivity to AFP-positive hepatoma and the high affinity between antiAFPMcAb and AFP antigen can assist 131I and GCV carried by the nanospheres to concentrate in hepatoma tissue. This evidence concerns the gene AFP and hepatocellular carcinoma.